| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 13 |
| 1 | ETOPOSIDE | 12 |
| 2 | METHOTREXATE | 12 |
| 3 | TACROLIMUS | 12 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 5 | TACROLIMUS OINTMENT 0.1% | 11 |
| 6 | CYTARABINE | 9 |
| 7 | METHYLPREDNISOLONE | 9 |
| 8 | VORICONAZOLE | 9 |
| 9 | VORICONAZOLE INJECTION | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PLERIXAFOR | 1 | 0.0007 |
| 1 | MICAFUNGIN SODIUM | 4 | 0.0006 |
| 2 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| 3 | ITRACONAZOLE | 5 | 0.0004 |
| 4 | DEFLAZACORT | 1 | 0.0004 |
| 5 | PEGASPARGASE | 4 | 0.0003 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 2 | 0.0003 |
| 7 | VORICONAZOLE | 9 | 0.0003 |
| 8 | LINEZOLID | 8 | 0.0003 |
| 9 | AMPHOTERICIN B | 3 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 23 |
| 1 | Azole Antifungal [EPC] | 14 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 3 | Topoisomerase Inhibitor [EPC] | 12 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 5 | Oxazolidinone Antibacterial [EPC] | 8 |
| 6 | Alkylating Drug [EPC] | 7 |
| 7 | Asparagine-specific Enzyme [EPC] | 4 |
| 8 | BCL-2 Inhibitor [EPC] | 4 |
| 9 | Echinocandin Antifungal [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 1 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 2 | Asparagine-specific Enzyme [EPC] | 4 | 0.0003 |
| 3 | Oxazolidinone Antibacterial [EPC] | 8 | 0.0003 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 5 | Topoisomerase Inhibitor [EPC] | 12 | 0.0002 |
| 6 | Penem Antibacterial [EPC] | 4 | 0.0001 |
| 7 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 8 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |